The review concluded that percutaneous coronary intervention was comparable with coronary artery bypass grafting for treating unprotected left main artery stenosis for the composite outcome of death, myocardial infraction, repeat revascularisation and stroke at 12 months follow-up. The review had some methodological and data limitations so a degree of caution is warranted when interpreting the authors' conclusions.
To compare percutaneous coronary intervention and coronary artery bypass grafting for treatment of unprotected left main artery stenosis.
Searching
PubMed, EMBASE and Cochrane Central Register of Controlled Trials (CENTRAL) were searched. Search terms were reported. No search dates were reported. Ongoing clinical trials and unpublished studies were searched on three online sites. Reference lists of retrieved articles were searched and textbooks were handsearched.
Study selection
Randomised controlled trials (RCTs) of percutaneous coronary intervention versus coronary artery bypass grafting in patients with unprotected left main artery stenosis and a minimum length of follow-up of 12 months were eligible for inclusion. The primary outcome was the composite of death, myocardial infarction, repeat revascularisation and stroke at 12 months follow-up. Secondary endpoints were the composite of death, myocardial infarction and repeat revascularisation; death; myocardial infraction; repeat revascularisation; graft failure; stent thrombosis; and stroke. Trials were excluded if they were ongoing, unpublished or published only as an abstract.
The included trials studied percutaneous coronary intervention versus coronary artery bypass grafting in patients with unprotected left main artery stenosis. The type of stent used during percutaneous coronary intervention varied; most were drug eluting and one study used bare metal stents. The proportion of patients with off-pump coronary artery bypass grafting varied from 46% to 64%, where reported. The proportion of patients with three-vessel disease ranged from 17% to 75% in the coronary artery bypass grafting group and 11% to 60% in the percutaneous coronary intervention group.
The authors did not state how many reviewers performed study selection.
Assessment of study quality
Quality assessment was undertaken using Cochrane Collaboration criteria of randomisation, allocation concealment, blinding, incomplete outcome data, selective reporting and other biases.
The authors did not state how many reviewers undertook quality assessment.
Data extraction
Data were extracted on a variety of composite and individual coronary outcomes and used to calculate odds ratios (ORs) and 95% confidence intervals (CIs).
Two reviewers independently extracted data and disagreements were resolved by consensus.
Methods of synthesis
Mantel-Haenszel fixed-effect meta-analysis was used to calculate pooled odds ratios and 95% CIs. DerSimonian random-effects meta-analysis was used where statistical heterogeneity was detected. Sensitivity analysis was conducted using random-effects meta-analysis with relative risks in place of odds ratios. Statistical heterogeneity was assessed
